When accumulated in the tumor microenvironment, MDSCs produce and release IL-10, TGF-β, and other molecules that promote neo-angiogenesis and exert immunosuppressive activity, facilitating tumor growth, survival, and progression [41,47,48]. Here, IL10 is linked to neoplasm.